CD34 and systemic sclerosis: In fact, SSc patients with DUs were found not only to display lower levels of circulating lymphatic EPCs (defined as CD34+/CD133+/VEGFR-3+ cells), compared with both patients without DUs and healthy controls, but also lower levels of surface VEGFR-3 on such cells [42].